Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact

Tag: Van Herk Investments B.V.

Short: Van Herk Investments announces 10.07% Shareholding in Ablynx
January 24, 2017 Off

Short: Van Herk Investments announces 10.07% Shareholding in Ablynx

By Dino Mustafić

Van Herk Investments B.V. has become owner of more than 10% of Ablynx as it has crossed the 10% threshold and now…

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Quantum Computing Market Trends and Investment Opportunities 2025-2035 Featuring Profiles of 115 Companies – ResearchAndMarkets.com

January 14, 2026 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine